Who owns IKENA ONCOLOGY INC?
- Ticker: IKNA
- CUSIP Number: 45175g108
Tip: Access positions for across all investors
Analyze quarterly positions in Ikena Oncology with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Ikena Oncology stock
Who bought or sold IKENA ONCOLOGY INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Atlas Venture Life Science Advisors | 5.0M | $7.1M | 0% | Mar 2024 |
|
| BVF | 4.8M | $6.8M | 0% | Mar 2024 |
|
| Blue Owl Capital Holdings | 3.9M | $5.5M | 99% | Mar 2024 |
|
| OrbiMed Advisors | 3.5M | $5.0M | 0% | Mar 2024 |
|
| Omega Fund Management | 2.2M | $4.4M | 0% | Dec 2023 |
|
| BlackRock | 1.8M | $2.6M | 26% | Mar 2024 |
|
| Vanguard Group | 1.5M | $2.2M | 0% | Mar 2024 |
|
| Verition Fund Management | 1.1M | $1.6M | -34% | Mar 2024 |
|
| Geode Capital Management | 597k | $848k | 15% | Mar 2024 |
|
| NEA Management Company | 570k | $810k | 0% | Mar 2024 |
|
| Jacobs Levy Equity Management | 513k | $729k | 814% | Mar 2024 |
|
| Acuitas Investments | 398k | $565k | 100% | Mar 2024 |
|
| Adage Capital Partners GP | 288k | $409k | -29% | Mar 2024 |
|
| Acadian Asset Management | 283k | $400k | 2673% | Mar 2024 |
|
| Two Sigma Investments | 243k | $345k | 377% | Mar 2024 |
|
| Northern Trust | 234k | $333k | 18% | Mar 2024 |
|
| Barclays | 197k | $280k | -20% | Mar 2024 |
|
| Citadel Advisors | 159k | $226k | -11% | Mar 2024 |
|
| Sofinnova Ventures | 116k | $164k | 0% | Mar 2024 |
|
| Marshall Wace | 89k | $126k | 100% | Mar 2024 |
|
| Charles Schwab Investment Management | 86k | $122k | 0% | Mar 2024 |
|
| Bridgeway Capital Management | 82k | $117k | -28% | Mar 2024 |
|
| Two Sigma Advisers | 80k | $114k | 100% | Mar 2024 |
|
| Marquette Asset Management | 73k | $104k | 100% | Mar 2024 |
|
| Goldman Sachs Group | 73k | $103k | 208% | Mar 2024 |
|
| Bank of New York Mellon | 71k | $101k | 2% | Mar 2024 |
|
| Morgan Stanley | 49k | $70k | 215% | Mar 2024 |
|
| Dimensional Fund Advisors | 39k | $55k | 0% | Mar 2024 |
|
| Nuveen Asset Management | 36k | $52k | 10% | Mar 2024 |
|
| CornerCap Investment Counsel | 36k | $51k | 0% | Mar 2024 |
|
| XTX Topco | 35k | $50k | 100% | Mar 2024 |
|
| ADAR1 Capital Management | 35k | $50k | 100% | Mar 2024 |
|
| UBS Group | 33k | $47k | 55% | Mar 2024 |
|
| Rhumbline Advisers | 28k | $40k | 3% | Mar 2024 |
|
| Bank of America Corporation | 19k | $27k | -62% | Mar 2024 |
|
| American International | 15k | $30k | 24% | Dec 2023 |
|
| New York State Common Retirement Fund | 15k | $21k | 0% | Mar 2024 |
|
| Ensign Peak Advisors | 14k | $20k | -85% | Mar 2024 |
|
| Jpmorgan Chase & Co | 13k | $19k | -40% | Mar 2024 |
|
| SG Americas Securities | 13k | $18k | -38% | Mar 2024 |
|
| Wells Fargo & Company | 11k | $15k | 15% | Mar 2024 |
|
| Tower Research Capital | 8.9k | $13k | 140% | Mar 2024 |
|
| Citigroup | 5.8k | $8.2k | 25% | Mar 2024 |
|
| FMR | 5.8k | $8.2k | -100% | Mar 2024 |
|
| California State Teachers Retirement System | 3.5k | $5.0k | -36% | Mar 2024 |
|
| Baystate Wealth Management | 3.0k | $5.9k | 0% | Dec 2023 |
|
| Legal & General Group | 2.0k | $2.9k | 0% | Mar 2024 |
|
| Summit Investment Advisors | 1.8k | $2.5k | 0% | Mar 2024 |
|
| Amalgamated Bank | 717.00 | $999.999900 | -61% | Mar 2024 |
|
| Royal Bank of Canada | 707.00 | $0 | -94% | Mar 2024 |
|
| Farther Finance Advisors | 35.00 | $49.000000 | 100% | Mar 2024 |
|
| CWM | 3.00 | $0 | 100% | Mar 2024 |
|
| Nelson, Van Denburg & Campbell Wealth Management | 3.00 | $3.999900 | 100% | Mar 2024 |
|
Who sold out of Ikena Oncology?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| venBio Select Advisor | Sep 2023 | 1.6M | $7.1M |
| Artal Group | Dec 2023 | 1000k | $2.0M |
| Laurion Capital Management | Dec 2023 | 373k | $734k |
| Vida Ventures Advisors | Dec 2023 | 225k | $444k |
| Virtu Financial | Dec 2023 | 27k | $53k |
| Jane Street | Dec 2023 | 22k | $44k |
| Ing Investment Management | Sep 2023 | 11k | $48k |